Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

3,110 studies match

clinicaltrialsPublishedShowing 2,751–2,800 of 3,110 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00708214	BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer	completed	Phase 2	28	Boehringer IngelheimINDUSTRY	1	Dec 30, 2013	clinicaltrials
NCT00875979	A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab	completed	Phase 1 / Phase 2	67	Hoffmann-La RocheINDUSTRY	7	Dec 24, 2013